| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |